SOLACI-CACI 2021 | Day 4: Andreas Grüentzig Auditorium – Pediatric Sessions

✔️ Day 4, SOLACI-CACI 2021
✔️ Andreas Gruentzig Auditorium

👨‍🏫 Contents:

  • 00:05 – PICS Society – SOLACI Session
  • 01:43:46 – A Talk with Experts: How Do I Do it?
  • 02:52:42 – Controversial Topics: Do We Have an Answer?
  • 04:23:45 – My Nightmare Case!
  • 05:26:20 – Ventricular Septal Defect Closure… Déjà Vu?

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-CACI 2021 | Day 1: Main Arena Auditorium

✔️ Day 1, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 06:20 - TCT@SOLACI-CACI 2021 Session - "The Future of PCI" 01:33:19 - PCR@SOLACI-CACI 2021 Session 👉...

SOLACI-CACI 2021 | Day 2: Main Arena Auditorium

✔️ Day 2, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:01 - TCT@SOLACI-CACI 2021 Session: "Structural Heart Interventions" 01:30:26 - CRT@SOLACI-CACI 2021 Session 02:51:13 - Oral...

SOLACI-CACI 2021 | Day 3: Main Arena Auditorium

✔️ Day 3 Completo, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:05 - CBS@SOLACI-CACI Session 01:43:26 - CCI@SOLACI-CACI Session 03:07:38 - Oral presentation – Structural III 04:32:21 -...

SOLACI-CACI 2021 | Day 4: Main Arena Auditorium

✔️ Day 4, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:09 - The MIL Group/SOLACI/CACI/WAO Gender Opportunities in Interventional Cardiology 01:30:55 - Current and Immediate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....